United States: MedSuite: Urology Market Size, Share & Trends Analysis | 2024-2030 | Includes: Urinary Incontinence Devices, Stone Management Devices, and 7 more

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $7,995	537 Pages	iData Research, Inc.	April, 2024	IDR18945058

Best Price Guarantee
Price	from $7,995
Length	537 Pages
Publisher	iData Research, Inc.
Published Date	April, 2024
SKU	IDR18945058

Urology Market Size, Share & Trends Analysis - United States - 2024-2030 - MedSuite - Includes: Urinary Incontinence Devices, Stone Management Devices, and 7 more

CAGR of 5.7%, reaching nearly $6.5 billion by the end of the forecast period.

The comprehensive report on the U.S. market for urological devices covers various segments, including urinary incontinence devices, stone management devices, benign prostate hyperplasia (BPH) treatment devices, urological endoscopes, prostate cancer treatment devices, urodynamic equipment, nephrostomy devices, men's reproductive health devices, and urinary guidewires.

MARKET REPORT DATA TYPES INCLUDED

Unit Sales, Average Selling Prices, Market Value & Growth Trends
10 Year Scope
Market Drivers & Limiters for Each Segment
Competitive Analysis with Market Shares for Each Segment
Recent Mergers & Acquisitions
Disease Overviews and Demographic Information
Company Profiles, Product Portfolios and SWOT for Top Competitors

As hospitals continue to expand their acquisitions of outpatient facilities and group purchasing organizations (GPOs) grow their influence, coupled with ongoing cuts in reimbursement rates in the urology sector, Average Selling Prices (ASPs) are likely to face ongoing pressure, potentially stifling future market growth.

Since its U.S. debut in 2013, NeoTract’s UroLift® has seen rapid adoption among urologists for the treatment of Benign Prostatic Hyperplasia (BPH), mirroring its popularity in regions including Europe, Canada, and Australia. This minimally invasive procedure offers a quick recovery, enhancing its appeal. The 2017 acquisition of NeoTract by Teleflex has bolstered UroLift®’s market penetration, benefiting from Teleflex’s extensive sales network. In September 2021, the launch of the UroLift Advanced Tissue Control (ATC)® and UroLift® 2 systems aimed to enhance patient safety and reduce logistical burdens, building on the original’s clinical success.

MARKET SEGMENTATION SUMMARY

While this report suite contains all applicable market data, each of the markets are also available as stand alone MedCore reports. This allows you to get access to only the specific market segment research that you need. You can view all these included reports and segmentation here:

Urinary Incontinence Devices Market – MedCore – The market for urinary incontinence treatments includes urinary catheters, urethral bulking agents, incontinence management devices, and urinary bags.

Stone Management Devices – MedCore – The total market for stone management devices includes ESWL capital equipment, ISWL equipment, Holmium lasers, Thulium lasers, stone fragment retrieval devices, ureteral stents, access sheaths.

BPH Treatment Devices – MedCore – The BPH treatment device market includes devices used for TURP, TUMT, TUNA, temporary prostatic stent, laser BPH, UroLift®, Rezum® and iTind® procedures.

Urological Endoscope – MedCore – The urological endoscope market includes cystoscopes, ureteroscopes, resectoscopes and nephroscopes.

Prostate Cancer Treatment Devices – MedCore – The prostate cancer treatment device market includes brachytherapy devices, cryotherapy ablation devices, and hydrogel rectal spacers.

Urodynamic Equipment Market – MedCore – The market for urodynamic equipment includes urodynamic equipment and urodynamic sonsumables.

Nephrostomy Devices – MedCore – The market for nephrostomy devices includes percutaneous nephrostomy sets, nephrostomy balloon catheters and nephrostomy drainage tubes.

Men’s Reproductive Health Market – MedCore – The total market for men’s reproductive health treatment devices includes inflatable erectile dysfunction devices, malleable erectile dysfunction devices, vacuum assisted erectile dysfunction devices, and testicular implants.

Urinary Guidewire Market – MedCore – The market for guidewires includes all guidewires to be used in urological procedures.CAGR of 5.7%, reaching nearly $6.5 billion by the end of the forecast period.

The comprehensive report on the U.S. market for urological devices covers various segments, including urinary incontinence devices, stone management devices, benign prostate hyperplasia (BPH) treatment devices, urological endoscopes, prostate cancer treatment devices, urodynamic equipment, nephrostomy devices, men's reproductive health devices, and urinary guidewires.

MARKET REPORT DATA TYPES INCLUDED

Unit Sales, Average Selling Prices, Market Value & Growth Trends
10 Year Scope
Market Drivers & Limiters for Each Segment
Competitive Analysis with Market Shares for Each Segment
Recent Mergers & Acquisitions
Disease Overviews and Demographic Information
Company Profiles, Product Portfolios and SWOT for Top Competitors

As hospitals continue to expand their acquisitions of outpatient facilities and group purchasing organizations (GPOs) grow their influence, coupled with ongoing cuts in reimbursement rates in the urology sector, Average Selling Prices (ASPs) are likely to face ongoing pressure, potentially stifling future market growth.

Since its U.S. debut in 2013, NeoTract’s UroLift® has seen rapid adoption among urologists for the treatment of Benign Prostatic Hyperplasia (BPH), mirroring its popularity in regions including Europe, Canada, and Australia. This minimally invasive procedure offers a quick recovery, enhancing its appeal. The 2017 acquisition of NeoTract by Teleflex has bolstered UroLift®’s market penetration, benefiting from Teleflex’s extensive sales network. In September 2021, the launch of the UroLift Advanced Tissue Control (ATC)® and UroLift® 2 systems aimed to enhance patient safety and reduce logistical burdens, building on the original’s clinical success.

MARKET SEGMENTATION SUMMARY

While this report suite contains all applicable market data, each of the markets are also available as stand alone MedCore reports. This allows you to get access to only the specific market segment research that you need. You can view all these included reports and segmentation here:

Urinary Incontinence Devices Market – MedCore – The market for urinary incontinence treatments includes urinary catheters, urethral bulking agents, incontinence management devices, and urinary bags.

Stone Management Devices – MedCore – The total market for stone management devices includes ESWL capital equipment, ISWL equipment, Holmium lasers, Thulium lasers, stone fragment retrieval devices, ureteral stents, access sheaths.

BPH Treatment Devices – MedCore – The BPH treatment device market includes devices used for TURP, TUMT, TUNA, temporary prostatic stent, laser BPH, UroLift®, Rezum® and iTind® procedures.

Urological Endoscope – MedCore – The urological endoscope market includes cystoscopes, ureteroscopes, resectoscopes and nephroscopes.

Prostate Cancer Treatment Devices – MedCore – The prostate cancer treatment device market includes brachytherapy devices, cryotherapy ablation devices, and hydrogel rectal spacers.

Urodynamic Equipment Market – MedCore – The market for urodynamic equipment includes urodynamic equipment and urodynamic sonsumables.

Nephrostomy Devices – MedCore – The market for nephrostomy devices includes percutaneous nephrostomy sets, nephrostomy balloon catheters and nephrostomy drainage tubes.

Men’s Reproductive Health Market – MedCore – The total market for men’s reproductive health treatment devices includes inflatable erectile dysfunction devices, malleable erectile dysfunction devices, vacuum assisted erectile dysfunction devices, and testicular implants.

Urinary Guidewire Market – MedCore – The market for guidewires includes all guidewires to be used in urological procedures.

executive summary
U.S. Urological Device Market Overview: Competitive Analysis; Market Trends; Market Developments; Procedure Included; Procedure Codes Investigated; Markets Included; Key Report Updates; Version History
research methodology: Step 1: Project Initiation & Team Selection; Step 2: Prepare Data Systems and Perform Secondary Research; Step 3: Preparation for Interviews & Questionnaire Design; Step 4: Performing Primary Research; Step 5: Research Analysis: Establishing Baseline Estimates; Step 6: Market Forecast and Analysis; Step 7: Identify Strategic Opportunities; Step 8: Final Review and Market Release; Step 9: Customer Feedback and Market Monitoring
impact of covid-19 on THE U.S. Urological Device Market: 2.1 Introduction; 2.2 Analysis By Market Segment
Disease overview: 3.1 Basic Anatomy; 3.2 Disease Treatment and Diagnostics; 3.3 Patient Demographics
Product Assessment: 4.1 Introduction; 4.2 Product Portfolios; 4.3 Regulatory Issues and Recalls; 4.4 Clinical Trials
U.S. Urological Device Market Overview: 5.1 Introduction; 5.2 Market Overview & Trend Analysis; 5.3 Drivers and Limiters; 5.4 Competitive Market Share Analysis; 5.5 Mergers and Acquisitions; 5.6 Company Profiles; 5.7 SWOT Analysis
Procedure Numbers: 6.1 Procedure Codes Investigated; 6.2 Procedure Overview
Urinary Incontinence Device Market: 7.1 Introduction; 7.2 Market Overview; 7.3 Market Analysis and Forecast; 7.4 Drivers and Limiters; 7.5 Competitive Market Share Analysis
Stone Management Device Market: 8.1 Introduction; 8.2 Market Overview; 8.3 Market Analysis and Forecast; 8.4 Drivers and Limiters; 8.5 Competitive Market Share Analysis
BPH Treatment Device Market: 9.1 Introduction; 9.2 Market Overview; 9.3 Market Analysis and Forecast; 9.4 Drivers and Limiters; 9.5 Competitive Market Share Analysis
Urological Endoscope Market: 10.1 Introduction; 10.2 Market Overview; 10.3 Market Analysis and Forecast; 10.4 Drivers and Limiters; 10.5 Competitive Market Share Analysis
Prostate Cancer Treatment Device Market: 11.1 Introduction; 11.2 Market Overview; 11.3 Market Analysis and Forecast; 11.4 Drivers and Limiters; 11.5 Competitive Market Share Analysis
Urodynamic Equipment Market: 12.1 Introduction; 12.2 Market Overview; 12.3 Market Analysis and Forecast; 12.4 Drivers and Limiters; 12.5 Competitive Market Share Analysis
Nephrostomy Device Market: 13.1 Introduction; 13.2 Market Overview; 13.3 Market Analysis and Forecast; 13.4 Drivers and Limiters; 13.5 Competitive Market Share Analysis
Men’s Reproductive Health Market: 14.1 Introduction; 14.2 Market Overview; 14.3 Market Analysis and Forecast; 14.4 Drivers and Limiters; 14.5 Competitive Market Share Analysis
Urinary Guidewire Market: 15.1 Introduction; 15.2 Market Analysis and Forecast; 15.3 Drivers and Limiters; 15.4 Competitive Market Share Analysis; Chart 1-1: Urological Device Market by Segment, U.S., 2023 – 2030; Chart 1-2: Urological Device Market Overview, U.S., 2023 & 2030; Chart 2-1: Multi-Scenario Urological Device Market Forecast, U.S., 2020 – 2030 (US$M); Chart 5-1: Urological Device Market by Segment, U.S., 2020 – 2030; Chart 5-2: Leading Competitors, Urological Device Market, U.S., 2023; Chart 6-1: Urology Market Procedures by Segment, U.S., 2020 – 2030; Chart 7-1: Urinary Incontinence Device Market by Segment, U.S., 2020 – 2030; Chart 7-2: Leading Competitors, Urinary Incontinence Device Market, U.S., 2023; Chart 8-1: Stone Management Device Market by Segment, U.S., 2020 – 2030; Chart 8-2: Leading Competitors, Stone Management Device Market, U.S., 2023; Chart 9-1: BPH Treatment Device Market by Segment, U.S., 2020 – 2030; Chart 9-2: Leading Competitors, BPH Treatment Device Market, U.S., 2023; Chart 10-1: Urological Endoscope Market by Segment, U.S., 2020 – 2030; Chart 10-2: Urological Endoscope Market by Condition, U.S., 2020 – 2030; Chart 10-3: Leading Competitors, Urological Endoscope Market, U.S., 2023; Chart 11-1: Prostate Cancer Treatment Device Market by Segment, U.S., 2020 – 2030; Chart 11-2: Leading Competitors, Prostate Cancer Treatment Device Market, U.S., 2023; Chart 12-1: Urodynamic Equipment Market by Segment, U.S., 2020 – 2030; Chart 12-2: Leading Competitors, Urodynamic Equipment Market, U.S., 2023; Chart 13-1: Nephrostomy Device Market by Segment, U.S., 2020 – 2030; Chart 13-2: Leading Competitors, Nephrostomy Device Market, U.S., 2023; Chart 14-1: Men’s Reproductive Health Market by Segment, U.S., 2020 – 2030; Chart 14-2: Leading Competitors, Men’s Reproductive Health Market, U.S., 2023; Chart 15-1: Urinary Guidewire Market, U.S., 2020 – 2030; Chart 15-2: Leading Competitors, Urinary Guidewire Market, U.S., 2023; Figure 1-1: Urological Device Market Share Ranking by Segment, U.S., 2023 (1 of 2); Figure 1-2: Urological Device Market Share Ranking by Segment, U.S., 2023 (2 of 2); Figure 1-3: Companies Researched in This Report (1 of 2); Figure 1-4: Companies Researched in This Report (2 of 2); Figure 1-5: Factors Impacting the Urological Device Market by Segment, U.S. (1 of 2); Figure 1-6: Factors Impacting the Urological Device Market by Segment, U.S. (2 of 2); Figure 1-7: Recent Events in the Urological Device Market, U.S., 2020 – 2024; Figure 1-8: Urological Device Procedures Covered (1 of 3); Figure 1-9: Urological Device Procedures Covered (2 of 3); Figure 1-10: Urological Device Procedures Covered (3 of 3); Figure 1-11: Procedure Codes Investigated; Figure 1-12: Urological Device Markets Covered (1 of 6); Figure 1-13: Urological Device Markets Covered (2 of 6); Figure 1-14: Urological Device Markets Covered (3 of 6); Figure 1-15: Urological Device Markets Covered (4 of 6); Figure 1-16: Urological Device Markets Covered (5 of 6); Figure 1-17: Urological Device Markets Covered (6 of 6); Figure 1-18: Key Report Updates; Figure 1-19: Version History; Figure 2-1: Urological Device Market by Segment, Worst Case Scenario, U.S., 2020 – 2030 (US$M) (1 of 2); Figure 2-2: Urological Device Market by Segment, Worst Case Scenario, U.S., 2020 – 2030 (US$M) (2 of 2); Figure 2-3: Urological Device Market by Segment, Base Case Scenario, U.S., 2020 – 2030 (US$M) (1 of 2); Figure 2-4: Urological Device Market by Segment, Base Case Scenario, U.S., 2020 – 2030 (US$M) (2 of 2); Figure 2-5: Urological Device Market by Segment, Best Case Scenario, U.S., 2020 – 2030 (US$M) (1 of 2); Figure 2-6: Urological Device Market by Segment, Best Case Scenario, U.S., 2020 – 2030 (US$M) (2 of 2); Figure 4-1: Urinary Incontinence Treatments by Company (1 of 2); Figure 4-2: Urinary Incontinence Treatments by Company (2 of 2); Figure 4-3: Stone Management Devices by Company (1 of 4); Figure 4-4: Stone Management Devices by Company (2 of 4); Figure 4-5: Stone Management Devices by Company (3 of 4); Figure 4-6: Stone Management Devices by Company (4 of 4); Figure 4-7: BPH Treatments by Company; Figure 4-8: Urological Endoscopes by Company (1 of 2); Figure 4-9: Urological Endoscopes by Company (2 of 2); Figure 4-10: Prostate Cancer Treatments by Company; Figure 4-11: Urodynamic Equipment and Consumables by Company; Figure 4-12: Nephrostomy Devices by Company; Figure 4-13: Men’s Reproductive Health Devices by Company; Figure 4-14: Urinary Guidewires by Company; Figure 4-15: Class 2 Device Recall BARD Magic3 GO; Figure 4-16: Class 2 Device Recall BULKAMID, URETHRAL BULKING SYSTEM; Figure 4-17: Class 2 Device Recall COAPTITE; Figure 4-18: Class 2 Device Recall Medline Silicone Foley catheter; Figure 4-19: Class 2 Device Recall SureStep; Figure 4-20: Class 2 Device Recall AMS 700 100 mL Spherical Reservoir with InhibiZone; Figure 4-21: Class 3 Device Recall Teleflex MEDICAL RuSCH One piece Male External Medium Catheter W/O Tape; Figure 4-22: Class 2 Device Recall AMS 800 Artificial Urinary Sphincter AMS 800 Belt Cuff; Figure 4-23: Class 3 Device Recall RUSCH Urinary Drainage bag; Figure 4-24: Class 2 Device Recall Rusch EasyCath Kit; Figure 4-25: Class 2 Device Recall UroPass Ureteral Access Sheath; Figure 4-26: Class 2 Device Recall Cook Medical Kwart RetroInject Ureteral Stent; Figure 4-27: Class 2 Device Recall Contour VL Ureteral Stent Set; Figure 4-28: Class 2 Device Recall Cook Medical; Figure 4-29: Class 2 Device Recall Polaris Ultra Ureteral Stent Set; Figure 4-30: Class 2 Device Recall Percuflex Plus Ureteral Stent Set; Figure 4-31: Class 2 Device Recall Stretch VL Ureteral Stent Set; Figure 4-32: Class 2 Device Recall Universa Firm Ureteral Stent; Figure 4-33: Class 2 Device Recall Universa Soft Ureteral Stent; Figure 4-34: Class 2 Device Recall SofFlex Double Pigtail Ureteral Stent; Figure 4-35: Class 2 Device Recall Urolift System; Figure 4-36: Class 3 Device Recall GreenLight HPSEA Laser Fibers; Figure 4-37: Class 2 Device Recall MoXy Laser Fiber; Figure 4-38: Class 2 Device Recall AURIGA 30 BRAZIL ZERO COST SYSTEM; Figure 4-39: Class 2 Device Recall Dornier; Figure 4-40: Class 2 Device Recall Olympus; Figure 4-41: Class 2 Device Recall OLYMPUS HF Resection Electrodes; Figure 4-42: Class 2 Device Recall KARL STORZ Flexible Video CystoUrethroscopes (CVIEW); Figure 4-43: Class 2 Device Recall Flexible Cystoscope; Figure 4-44: Class 2 Device Recall SpaceOAR Vue System; Figure 4-45: Class 2 Device Recall IcePearl 2.1 CX 90 Cyroablation Needles; Figure 4-46: Class 2 Device Recall IceSphere Cryoablation Needles; Figure 4-47: Class 2 Device Recall VisualICE MRI MCP; Figure 4-48: Class 2 Device Recall Visual ICE Cryoablation System; Figure 4-49: Class 2 Device Recall Percutaneous Neonatal Pigtail Nephrostomy Set and Pediatric Nephrostomy Stent Set; Figure 4-50: Class 2 Device Recall Percutaneous Pigtail Nephrostomy Set; Figure 4-51: Class 2 Device Recall Percutaneous Malecot Nephrostomy Set; Figure 4-52: Class 2 Device Recall Percutaneous Entry Set; Figure 4-53: Class 2 Device Recall Torosa; Figure 4-54: Class 2 Device Recall the AMS 700 Inflatable Penile Prosthesis; Figure 4-55: Class 2 Device Recall Titan Pump; Figure 4-56: Class 2 Device Recall AMS 700 Inflatable Penile Prosthesis; Figure 4-57: Class 2 Device Recall AMS 700 100 mL Spherical Reservoir with InhibiZone; Figure 4-58: Post-Market Clinical Follow-Up on TVT EXACT® Continence System; Figure 4-59: Single-incision Versus Retropubic Mid-Urethral Sling (Solyx) for SUI during Minimally Invasive Sacrocolpopexy (SASS); Figure 4-60: Artificial Urinary Sphincter Clinical Outcomes (AUSCO); Figure 4-61: e۰Sense® Catheter Clinical Investigation; Figure 4-62: Investigation of Non-CE Marked Intermittent Catheters for Females; Figure 4-63: Exploratory Study of a New Urine Collection Device for Men; Figure 4-64: Investigation of New Intermittent Catheters in Healthy Volunteers; Figure 4-65: Safety and Device Performance of the Uriprene® Degradable Temporary Ureteral Stent Following Uncomplicated Ureteroscopy (URIPRENE); Figure 4-66: The RELIEF™ Ureteral Stent - Assessment of Retrograde Urinary Reflux and Distal Coil Bladder Position; Figure 4-67: Double-J PLUS Postmarket Registry; Figure 4-68: A Randomized, International Study to Assess the Safety of iTind Compared to UroLift; Figure 4-69: Comparing UroLift Experience Against Rezūm; Figure 4-70: A Study Comparing Urolift and TURP Ahead of Radiotherapy in Men with Urinary Symptoms Secondary to Prostate Enlargement; Figure 4-71: UroLift System with SAbR for Prostate Cancer and BPH; Figure 4-72: Comparing UroLift Experience Against Rezūm (CLEAR); Figure 4-73: To Evaluate the Feasibility, Preliminary Safety and Performance of Rezūm System in BPH Treatment in China; Figure 4-74: Evaluation of Novel Disposable Flexible Ureteroscope for the Treatment of Renal Calculi; Figure 4-75: Prospective Evaluation of the LithoVue Elite Ureteroscope; Figure 4-76: Effectiveness of Ambu® aScope™ 4 Cysto With the aView™ 2 Advance for Flexible Cystoscopy; Figure 4-77: Single-use Cystoscope System for Direct Visualization of the Urethra and Bladder; Figure 4-78: Evaluation of Performance and Safety of Ambu® aScope™ 4 Cysto and aView™ Urologia for Flexible Cystoscopy; Figure 4-79: Multi-omic Approach to Study HDR Brachytherapy for Favorable Risk and Low Tier Intermediate Risk Prostate Cancer; Figure 4-80: Focal Ablation with Focal Cryotherapy or HIFU for the Treatment of Men with Localized Prostate Cancer; Figure 4-81: Using Rectal Hydrogel Spacer for Salvage SABR in Prostate Cancer; Figure 4-82: LDR vs. HDR Brachytherapy for Prostate Cancer (LDR/HDRmono); Figure 4-83: Rectal Spacer Hydrogel Before Radiation Therapy in Reducing Radiation Dose to the Rectum in Patients with Prostate Cancer; Figure 4-84: Prospective Observational Study on SEBBIN Silicone Gel-filled Testicular Implants; Figure 4-85: Penile Prosthesis in Patients with Erectile Dysfunction; Figure 4-86: Safety and Efficacy Study of USTRAP™ in Male Urinary Incontinence (PROSPECT); Figure 4-87: Rigicon Infla10® Three-Piece Inflatable Penile Prosthesis; Figure 5-1: Urological Device Market by Segment, U.S., 2020 – 2030 (US$M) (1 of 2); Figure 5-2: Urological Device Market by Segment, U.S., 2020 – 2030 (US$M) (2 of 2); Figure 5-3: Leading Competitors, Urological Device Market, U.S., 2023 (1 of 2); Figure 5-4: Leading Competitors, Urological Device Market, U.S., 2023 (2 of 2); Figure 5-5: SWOT Analysis, Becton Dickinson; Figure 5-6: SWOT Analysis, Boston Scientific; Figure 5-7: SWOT Analysis, Cardinal Health; Figure 5-8: SWOT Analysis, Coloplast; Figure 5-9: SWOT Analysis, Cook Medical; Figure 5-10: SWOT Analysis, Elekta; Figure 5-11: SWOT Analysis, Ethicon; Figure 5-12: SWOT Analysis, Karl Storz; Figure 5-13: SWOT Analysis, Laborie; Figure 5-14: SWOT Analysis, Medline; Figure 5-15: SWOT Analysis, Olympus; Figure 5-16: SWOT Analysis, Siemens; Figure 5-17: SWOT Analysis, Teleflex; Figure 6-1: Procedure Codes Investigated, U.S., 2023; Figure 6-2: Urological Procedures by Segment, U.S., 2020 – 2030 (1 of 2); Figure 6-3: Urological Procedures by Segment, U.S., 2020 – 2030 (2 of 2); Figure 6-4: Urinary Incontinence Management Procedures by Segment, U.S., 2020 – 2030; Figure 6-5: Male Urinary Incontinence Management Procedures by Segment, U.S., 2020 – 2030; Figure 6-6: Female Urinary Incontinence Management Procedures by Segment, U.S., 2020 – 2030; Figure 6-7: Stone Management Procedures by Segment, U.S., 2020 – 2030; Figure 6-8: ESWL Procedures, U.S., 2020 – 2030; Figure 6-9: Transurethral Procedures by Segment, U.S., 2020 – 2030; Figure 6-10: Ureteral Stent Procedures, U.S., 2020 – 2030; Figure 6-11: PCNL Procedures, U.S., 2020 – 2030; Figure 6-12: Ureteroscopy Procedures by Device Type, U.S., 2020 – 2030; Figure 6-13: Cystoscopy Procedures by Device Type, U.S., 2020 – 2030; Figure 6-14: BPH Patient Statistics, U.S., 2020 – 2030; Figure 6-15: BPH Procedures by Segment, U.S., 2020 – 2030 (1 of 2); Figure 6-16: BPH Procedures by Segment, U.S., 2020 – 2030 (2 of 2); Figure 6-17: BPH Procedures by Care Setting, U.S., 2020 – 2030; Figure 6-18: BPH Procedures by Care Setting (Hospital), U.S., 2020 –2030 (1 of 2); Figure 6-19: BPH Procedures by Care Setting (Hospital), U.S., 2020 –2030 (2 of 2); Figure 6-20: BPH Procedures by Care Setting (ASC), U.S., 2020 –2030 (1 of 2); Figure 6-21: BPH Procedures by Care Setting (ASC), U.S., 2020 –2030 (2 of 2); Figure 6-22: BPH Procedures by Care Setting (Office), U.S., 2020 –2030 (1 of 2); Figure 6-23: BPH Procedures by Care Setting (Office), U.S., 2020 –2030 (2 of 2); Figure 6-24: BPH Patient Statistics, U.S., 2020 – 2030; Figure 6-25: Prostate Cancer Treatment Procedures by Segment, U.S., 2020 – 2030; Figure 6-26: Watchful Waiting Procedures, U.S., 2020 – 2030; Figure 6-27: Prostatectomy Procedures by Segment, U.S., 2020 – 2030; Figure 6-28: Open Prostatectomy Procedures by Segment, U.S., 2020 – 2030; Figure 6-29: Ablation Procedures by Segment, U.S., 2020 – 2030; Figure 6-30: Radiation Therapy Procedures by Segment, U.S., 2020 – 2030; Figure 6-31: HDR Brachytherapy Procedures by Segment, U.S., 2020 – 2030; Figure 6-32: LDR Brachytherapy Procedures by Segment, U.S., 2020 – 2030; Figure 6-33: External Radiation Therapy Procedures by Segment, U.S., 2020 – 2030; Figure 6-34: Urodynamic Testing Procedures by Segment, U.S., 2020 – 2030; Figure 6-35: Cystometrogram Procedures by Segment, U.S., 2020 – 2030; Figure 6-36: Uroflowmetry Procedures by Segment, U.S., 2020 – 2030; Figure 6-37: Nephrostomy Procedures by Segment, U.S., 2020 – 2030; Figure 6-38: Erectile Dysfunction Management Procedures by Segment, U.S., 2020 – 2030; Figure 7-1: Urinary Incontinence Device Market by Segment, U.S., 2020 – 2030 (US$M); Figure 7-2: Urinary Catheter Market by Segment, U.S., 2020 – 2030 (US$M); Figure 7-3: Intermittent Catheter Market by Segment, U.S., 2020 – 2030 (US$M); Figure 7-4: Total Intermittent Catheter Market, U.S., 2020 – 2030; Figure 7-5: Coated Intermittent Catheter Market, U.S., 2020 – 2030; Figure 7-6: Uncoated Intermittent Catheter Market by Segment, U.S., 2020 – 2030 (US$M); Figure 7-7: Uncoated Latex-Free Intermittent Catheter Market, U.S., 2020 – 2030; Figure 7-8: Uncoated Latex Intermittent Catheter Market, U.S., 2020 – 2030; Figure 7-9: Closed-System Intermittent Catheter Market by Segment, U.S., 2020 – 2030 (US$M); Figure 7-10: Gel Closed-System Intermittent Catheter Market, U.S., 2020 – 2030; Figure 7-11: Hydrophilic and Antimicrobial Closed-System Intermittent Catheter Market, U.S., 2020 – 2030; Figure 7-12: Foley Catheter Market by Segment, U.S., 2020 – 2030 (US$M); Figure 7-13: Total Foley Catheter Market, U.S., 2020 – 2030; Figure 7-14: Latex Foley Catheter Market, U.S., 2020 – 2030; Figure 7-15: Latex-Free Foley Catheter Market by Segment, U.S., 2020 – 2030 (US$M)

PDF E-mail From Publisher:	$7,995
Multi-User License (2-5 users):	$8,995
Global Site License Fulfilled by Publisher:	$9,995

Show additional purchase options...

Research Assistance

US: 800.298.5699

Int'l: +1.240.747.3093

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

United States: MedSuite: Urology Market Size, Share & Trends Analysis | 2024-2030 | Includes: Urinary Incontinence Devices, Stone Management Devices, and 7 more

Urology Market Size, Share & Trends Analysis - United States - 2024-2030 - MedSuite - Includes: Urinary Incontinence Devices, Stone Management Devices, and 7 more

Laparoscopic Devices Market Size, Share & COVID-19 Impact Analysis - United States - 2023-2029 - MedSuite - Includes: Laparoscopes, Access Devices, Closure Devices, and 8 more

Gynecological Devices Market Analysis, Size, Trends - United States - 2023-2029 - MedSuite - Includes: Gynecological Endoscope Devices, Endometrial Ablation Devices, Morcellator Device Market and 7 more.

ENT & Bronchoscopy Devices Market Size, Share, & COVID-19 Impact Analysis - United States - 2023-2029 - MedSuite - Includes: ENT Endoscopes, ENT Powered Instruments, and 9 more

MedSuite: United States Anesthesia, Respiratory & Sleep Therapy Devices Market Size, Share & Trends Analysis | 2023-2029 | Includes: Anesthesia Delivery Units (ADUs), Ventilators, Nebulizers, and 7 more

Vascular Access Devices Market Size, Share & COVID-19 Impact Analysis-United States-2023-2029-MedSuite-Includes: Implantable Ports, Port Needles, Central Venous Catheters, and 12 more

MedSuite: United States Minimally Invasive Spinal Implant Market Size, Share & Trends Analysis - 2024-2030 - Includes: MIS Interbody Devices, MIS Pedicle Screws, Spinous Process Fixation, and 4 more

Research Assistance

Other tasks